Clinical Trials

Study Title:
A Phase III Randomized Trial of Radiotherapy Optimization for Low Risk HER2 Positive Breast Cancer\" (HERO)

For more information about the trial above please contact the study team:

Lexington Medical Center
Affiliate Principal Investigator, Madden, Steven, at samadden@lexhealth.org.
Study Coordinator, Madden, Katherine, at kdmadden@lexhealth.org.

Medical University of South Carolina
Principal Investigator, Eldredge-Hindy, Harriet, at eldredge@musc.edu.
Study Coordinator, Bargeloh, Zachary, at bargeloh@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina, Lexington Medical Center